- Department Head for Medical Affairs, including: Clinical Affairs, Clinical Operations, Clinical Development and Medical Communications. The Medical Affairs Department within Medline is comprised of 30+ personnel, responsible for overseeing the formulation and execution of a comprehensive clinical strategy for the company, encompassing: identification of business and regulatory needs (Clinical Affairs), study design and execution (Clinical Operations), communication of clinical results and publications tactics (Medical Communications), and development of a clinical research network through field-based Medical Affairs assets (Clinical Development). - Responsible for strategically aligning Medical Affairs within Medline and shaping the future of the Medical Affairs Organization. Providing leadership and direction to internal stakeholders while communicating with external customers, thought leaders, and key organizations and institutions.- Oversee creation and alignment of Medical Affairs policies and SOPs and develop training and organizational compliance in support of those policies.- Serve on product Advisory Boards and Independent Medical Education grants committees, while Chairing the Scientific Review Committee.- Variety of management responsibilities: manage through team leaders (comprised of directors and VPs); leadership and management of multiple operating units and sub-departments; strategic, tactical, and operational planning for the entire Medical Affairs function, including budgetary responsibility, policy creation/interpretation/execution, and all staffing logistics.

Dual role combining aspects of Research & Development and Scientific Affairs.- Team leader for Regenerative Medicine and Implant Performance Teams: cross-functional teams encompassing R&D, Marketing (Upstream, Downstream, International), Regulatory, Operations, Medical Affairs (US, International), Project Management and Publications Planning, focused on innovative assay and model development and science supporting 90% of the existing Allergan medical device portfolio (Natrelle Implants and Tissue Expanders, AlloDerm, Strattice, Revolve, Artia, Keller Funnel). Average annual cumulative operating budget ~$1.5M. Approximately 20-25 assigned personnel, managed in matrix structure.- Assist in identifying and assessing technologies as part of early Business Development ventures.- Point of scientific contact for: Medical Education, Key Opinion Leader (KOL)/clinical relationships, and interdepartmental communication with Sales, downstream Marketing and Sales Training.- Perform extensive messaging across various platforms vital to business success: bioskills labs, internal surgeon forums, external conferences and related dinners, sales meetings, advisory boards, hospital administration meetings, partners business visits, health care provider’s summits, and targeted individual surgeon meetings.- Member of R&D Leadership Team.

Working as primary inventor and scientific lead for projects in Colorectal space. Managing small team in new product and technology creation. Supporting role for competitor testing group.- Principal scientific presenter for Medical Education/Scientific Affairs, helping craft scientific message behind LifeCell product portfolio, and presenting to surgeon groups domestically and internationally, while also assisting in training and education of sales force.- Responsible for building and maintaining speaker presentation slide library, for new and existing products (ALLODERM, STRATTICE, REVOLVE, ARTIA, NovoMatrix).- Coordinate scientific training of Medical Science Liaisons.- Assist in interpretation of clinical biopsies and research initiatives, including differentiating through extensive competitive testing.

Team lead of program evaluating applications in wound healing space: developing large animal delayed healing models (partial and full-thickness burn injuries); testing novel dermis-based materials, both benchtop and preclinically.

Characterized traumatized muscle tissue collected from soldiers wounded during Operation Enduring Freedom, creating a biomimetic culture platform to evaluate mesenchymal stem cells isolated from surgical waste tissue. Worked with interdisciplinary team of military orthopaedic surgeons, geneticists and cell biologists to gain insight into molecular triggers of heterotopic ossification and fibrosis during pathological wound healing.

Fabricated synthetic and biological cell culture substrates, to assess effects of three-dimensionality on neural and hematopoietic stem cell cultures. Consulted Arteriocyte R&D laboratory in Cleveland, OH on development and production of NANEX biofunctional nanofiber-based 3D scaffolds for rapid stem cell expansion applications such as blood pharming.

Performed non-destructive mechanical testing of bovine/ovine/chimpanzee bone samples: oscillatory compression testing; dynamic mechanical 3-point bending; microcomputed tomography (micro CT).